OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Pyxis Oncology Appoints Thomas Civik as CEO and Chairman of the Board

Down Syndrome and Leukemia: How an Extra Copy of Chromosome 21 Changes Cancer Risk

Shaalan Beg: When AI Enters the Clinic

Arlocabtagene Autoleucel Meets Primary Endpoint in Phase 2 QUINTESSENTIAL Trial for Multiple Myeloma

Cureety Acquires Reimagine Care, Assembling a Transatlantic Platform for Cancer Care Between Visits

Oncology News, Insights, Stories by OncoDaily

Durvalumab
Lung Oncology

Durvalumab Plus Tarlatamab Improves Overall Survival in First-Line Extensive-Stage Small Cell Lung Cancer

Elizabeth Mittendorf
Voices

Elizabeth Mittendorf: Grateful to Represent ASCO at the KSMO Annual Meeting in Seoul

VIRO 2026 – Global Voices in Renal Oncology
OncoDaily

VIRO 2026 – Global Voices in Renal Oncology

Joe Biden: Prostate Cancer Awareness Month is More Personal for Me This Year

Sumanta K. Pal: Misalignment Between Clinical Trial Access and Disease Burden in US Bladder Cancer

David Planchard: New Biomarkers and Treatment Strategies in Advanced NSCLC

Asparaginase: The Unexpected Discovery Behind a Cornerstone of ALL Treatment

Elizabeth Mittendorf: Grateful to Represent ASCO at the KSMO Annual Meeting in Seoul

New Zealanders Have Spoken, Cancer Action Has a Public Mandate - Cancer Society of New Zealand

Highlights From World Radiotherapy Awareness Day

Voices
AIEOP

EXPeRT Scientific Meeting: Advancing Care for Very Rare Paediatric Tumours - AIEOP

Muhammad Asad: Better Access to Radiotherapy Means Better Cancer Outcomes

Khalid El Bairi: From Bachelor’s Degree to Publication - Nassima Bouzar’s Research Journey

Amer Zeidan: AI in Medicine Still Needs a Reality Check

Anna Ugalde: Behind the Work, the People, and the Purpose

Cassio Murilo Hidalgo Filho: Managing Tarlatamab in Small Cell Lung Cancer

Yin Ling Woo: Program ROSE Recognized as a Malaysian Model for Cancer Prevention

FDA Approvals
Ziihera

FDA Approves Ziihera With and Without Tislelizumab Plus Chemotherapy for First-Line HER2-Positive Gastroesophageal Adenocarcinoma

FDA Approves OncoSil Device for Distal Cholangiocarcinoma

FDA Grants Accelerated Approval to Bristol Myers Squibb’s Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma

FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

OncoDaily 100
100 Influential Women in Oncology

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential People in Oncology 2026 – Nominations are Open!

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

Celebrities and Cancer

OncoCalendar

OPN Southwest Chapter Conference 2026

Oncology Pharmacy Network

17 Oct
OPN Southwest Chapter Conference

17th Annual Comprehensive Hematology and Oncology Review Course

Fred Hutch Cancer Center

12 Oct
Hematology and Oncology Review

IAPCON 2027: 34th Annual International Conference of the Indian Association of Palliative Care

Indian Association of Palliative Care (IAPC)

19 Feb
IAPCON 2027

WIN Symposium 2026: Precision Oncology - Innovation and Equity Across the Globe

Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine

02 Oct
WIN Symposium 2026

4th Tanzania International Cancer Conference (TICC 2026)

Tanzania Oncology Society

02 Oct
Tanzania International Cancer Conference

Immune-oncology
3D Ex Vivo Lymphoma Spheroids

Can 3D Ex Vivo Lymphoma Spheroids Predict Immunotherapy Response? 

RATIONALE-306: Tislelizumab Plus Chemotherapy Shows Sustained 3-Year Survival Benefit in Advanced ESCC

Etentamig and the Next Wave of Immune Engagers in Multiple Myeloma

Dana-Farber Study Links CDK2 Activity With Response to Immune Checkpoint Blockade

Talquetamab in R/R Multiple Myeloma: Real-World Analysis From the IMWG Immunotherapy Registry

What Happens If CAR T-Cell Therapy Fails? Relapse, Refractory Disease, and Next Treatment Options

Anti-CD7 CAR T-Cell Therapy Shows Promising CNS Activity in Relapsed or Refractory T-ALL/LBL

Gastrointestinal-Oncology
Can Pancreatic Cancer Be Detected Early? Symptoms, Biomarkers, and New Tests

Can Pancreatic Cancer Be Detected Early? Symptoms, Biomarkers, and New Tests

Hepatocellular Carcinoma and Viral Hepatitis: How HBV and HCV Drive Liver Cancer

Esophageal Adenocarcinoma Biomarkers: HER2, PD-L1, MSI, CLDN18.2 and Emerging Targets

Esophageal Squamous Cell Carcinoma Biomarkers: PD-L1, Molecular Features and Emerging Targets

Ziihera Plus Chemotherapy Improves Overall Survival in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma

Phase 2 NEST Trial: Neoadjuvant BOT/BAL in Localized Colon Cancer

FDA Approves Daraxonrasib: First-in-Class RAS Inhibitor for Metastatic Pancreatic Cancer

Breast-Oncology
Anbenitamab

Anbenitamab Plus HB1801 Improves Pathologic Complete Response in HER2-Positive Early Breast Cancer

Breast Cancer Treatment Sequencing 2026: Powerful New Insights for Better Outcomes

Camizestrant and ctDNA-Guided Treatment Switching: A New Paradigm in ESR1-Mutant Advanced Breast Cancer

FDA Grants Accelerated Approval to Camizestrant for ESR1-Mutated Advanced Breast Cancer

Stage I TNBC Is Not One Risk Group: Can Immune Biology Identify Patients Who Need Less Treatment?

When Bone-Only HR+/HER2− Breast Cancer Turns Visceral: What PR Expression May Tell Us in the CDK4/6 Era

Enhertu Plus Pertuzumab Approved in the EU for First-Line HER2-Positive Metastatic Breast Cancer: A New Benchmark After More Than a Decade

Lung-Oncology
Sevabertinib

FDA Expands Accelerated Approval of Sevabertinib for HER2-Mutant Non-small Cell Lung Cancer

Targeted Therapy in Advanced NSCLC: From Driver Matching to Adaptive Precision Oncology

Durvalumab Plus Tarlatamab Improves Overall Survival in First-Line Extensive-Stage Small Cell Lung Cancer

Stage III NSCLC Management 2026: Powerful Advances Transforming Multimodal Care

Pulmonary Nodules in 2026: A Risk-Based Approach to Surveillance, Biopsy, and Definitive Treatment

Exercise in Lung Cancer Care: From Supportive Evidence to Global Implementation With IREX-Lung

Daraxonrasib Opens a Broader RAS-Targeting Strategy in Previously Treated NSCLC

OncoDaily TV
Christian Ntizimira

Continue to be human: Christian Ntizimira

Stephanie Kauffman

She Left Hollywood To Fight Cancer: Stephanie Kauffman

pablo allard

Childhood Cancer Survivor Who Changed the Law: Pablo Allard’s Advocacy Journey

Cancer Care

Personalizing Colorectal Cancer Care with ctDNA? Dr. Robert Lentz

Priti Patnaik, Independent journalism

Independent journalism in global health: Priti Patnaik

Treatment Paradigms, Karine Tawagi

Evolving Treatment Paradigms in Muscle-Invasive Bladder Cancer

Cancer in Women

Cancer in Women As a Global Health and Economic Issue: Dr. Maira Caleffi

oncoffee, palliative

ONCOFFEE: Colorectal Cancer, Palliative Care, and the Human Side of Oncology: Santiago Fontes

Empowering Oncologists

Empowering Oncologists: How Policy impacts Medicine?

WHO

Mission is possible: WHO said 2030 – Rwanda said 2027: Dr. Sabin Nsanzimana

Current Landscape

The Current Landscape and Future of CAR-T in Aggressive B-Cell Lymphoma

Experts by Experience

Experts by Experience with Carmen Monge

Not To Miss
Sevabertinib

FDA Expands Accelerated Approval of Sevabertinib for HER2-Mutant Non-small Cell Lung Cancer

Joe Biden Raises Prostate Cancer Awareness, Urges Men to Discuss Screening With Their Doctors

HHS Announces Four Key FDA Leadership Selections Across CDER, CBER, CTP and AI

Durvalumab Plus Tarlatamab Improves Overall Survival in First-Line Extensive-Stage Small Cell Lung Cancer

Arlocabtagene Autoleucel Meets Primary Endpoint in Phase 2 QUINTESSENTIAL Trial for Multiple Myeloma

Highlights From World Radiotherapy Awareness Day

OncoDaily Editor-in-Chief Gevorg Tamamyan Awarded 2026 Global Health Catalyst Distinguished Leader Award

OncoGrants
Translation of Technologies

NIH Academic–Industrial Partnerships for Translation of Technologies R01 Grant 2026

Independence K99/R00 Award

NCI Pathway to Independence K99/R00 Award 2026

CDMRP

CDMRP Breast Cancer Clinical Research Extension Award 2026

MD Young Investigator Award

MOASC Cary Presant, MD Young Investigator Award 2027

Excellence Mobility Programme

OECI Excellence Mobility Programme 2026 for Young Oncology Professionals

Osteosarcoma Research Grant

MIB Agents OutSmarting Osteosarcoma Research Grants 2027

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Enrique Soto Perez de Celis

Enrique Soto Pérez de Celis

Oncologists Location Aurora
C.S. Pramesh

C.S. Pramesh

Oncologists Location Mumbai, India
Michael Jefford

Michael Jefford

Oncologists Location Melbourne, Australia
Abeid Athman Omar

Abeid Athman Omar

Oncologists Location Nairobi, Kenya
Roshan Daniel

Roshan Daniel

Oncologists Location Thiruvananthapuram, India
Jackson Orem

Jackson Orem

Oncologists Location Kampala, Uganda
Dirk Arnold

Dirk Arnold

Oncologists Location Hamburg, Germany
Cristina Smolenschi

Cristina Smolenschi

Oncologists Location Villejuif, France

Oncology Drugs
OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

mRNA-4359: Promising Cancer Vaccine, Dose, Administration, and Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
Salman Punekar

Salman Punekar: Daraxonrasib Marks a New Era for RAS-Mutated Lung Cancer

Sacrococcygeal Teratomas

New Paper Alert: Multidisciplinary Management of Altman Type III Sacrococcygeal Teratomas in Benin

Jithma Abeykoon

Jithma Abeykoon: NGS Profiling Is Essential for All Rosai-Dorfman Disease Tumors

Jasmin Hundal

Jasmin Hundal: New Study Reveals Breast Cancer Disparities Among South Asian American Women

Kefah Mokbel

Kefah Mokbel: ctDNA Identifies Patients at Risk of Breast Cancer Relapse

Alberto Puccini, Humanitas University

Alberto Puccini: Long Non-Coding RNAs Open New Directions in Colorectal Cancer

OncoDaily Medical Journal

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

Oncology Nursing

10.69690/ODMJ-001-0826-7778

Real-World Patterns of Immune-Related Toxicity in Gastrointestinal Cancer Patients Treated with Immunotherapy: A service evaluation
Original Research

Oncology Nursing

10.69690/ODMJ-002-0826-7795

Late presentation in cancer care: Implications for treatment and survival: A Narrative Review
Reviews

GI Oncology

10.69690/ODMJ-018-0826-7959

From Plate to Polyps: Dietary N-Nitrosamines and Biomarkers of DNA Damage
Abstracts

Head and Neck Cancer

10.69690/ODMJ-018-0826-7933

A Service Review of PD-L1 Biomarker Use in the Head and Neck Cancer Service
Abstracts

Radiation Oncology

10.69690/ODMJ-018-0826-7920

Short-Course Palliative Radiotherapy for Tumour-Related Bleeding in End-of-Life Care: A Focused Literature Review
Abstracts

Pediatric Oncology

10.69690/ODMJ-018-0826-7952

FLASH radiotherapy: A Potential Way to Protect the Developing Brain in Pediatric Oncology
Abstracts

GI Oncology

10.69690/ODMJ-018-0826-7947

Real World Clinical Insights in Combination of Trifluridine-Tipiracil with Bevacizumab for Metastatic Colorectal Cancer
Abstracts